Our DiaComp pilot grant was selected for funding

Sep 24, 2021

1 min read

Our pilot award to DiaComp was selected for funding! The goal of this pilot study is to test novel podocyte protective compounds that emerged from a phenotypic screen in an animal model of diabetic kidney disease

Recent Posts

See All

New Foundation Funding

We have received a generous grant from the Hearst Foundation to support preclinical and IND-enabling studies on our drug candidate for spinal cord injury, TMP-316.

Our NCI RO1 received a 1.0 percentile score!!!

Our NCI R01 (Schatz, Ali) received a 1 percentile score. This grant aims to study the essential role of the cyclin-G associated kinase...

New DoD Funding

The Zeier and Ali labs received a DoD Therapeutic Idea Award. The goal of the project is to evaluate whether the spinal cord injury drug...

The Ali Lab at the University of Miami

Our DiaComp pilot grant was selected for funding

Recent Posts

Comments